SCHEMBL9449331

SCHEMBL9449331

CCc1cc(CCc2nc3ccccc3o2)c(=O)[nH]c1COCc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.44
RAB9A P51151 4/20 0.44
NPC1 O15118 3/20 0.44
APLNR P35414 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
TP53 P04637 2/20 0.40
HTT P42858 1/20 0.40
GFER P55789 1/20 0.40
HCAR2 Q8TDS4 2/20 0.39
KDM4E B2RXH2 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
HSD17B10 Q99714 1/20 0.38
LOXL2 Q9Y4K0 1/20 0.38
ELANE P08246 1/20 0.38
CDK5 Q00535 1/20 0.37
CDK5R1 Q15078 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9846186 0.88 MAPT (0.48) MAPTRAB9ANPC1APLNRSMN1; SMN2
SCHEMBL9846095 0.83 MAPT (0.50) MAPTRAB9ANPC1APLNRSMN1; SMN2
SCHEMBL9449230 0.83 MAPT (0.50) MAPTRAB9ANPC1APLNRSMN1; SMN2
SCHEMBL9682811 0.81 HCAR2 (0.37) MAPTRAB9ANPC1APLNRHCAR2
SCHEMBL5573693 0.80 MAPT (0.54) MAPTRAB9ANPC1APLNRSMN1; SMN2
SCHEMBL9680279 0.74 TSHR (0.41) MAPTRAB9AHCAR2CDK5CDK5R1
SCHEMBL9682115 0.72 HCAR2 (0.33) MAPTRAB9ANPC1HCAR2KDM4E
SCHEMBL9846131 0.72 MAPT (0.44) MAPTRAB9ANPC1SMN1; SMN2TP53
SCHEMBL9846311 0.72 MAPT (0.44) MAPTRAB9ANPC1SMN1; SMN2TP53
SCHEMBL9846076 0.72 MAPT (0.44) MAPTRAB9ANPC1SMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5202243-A Biosynthetic hydroxylation yields polymerase inhibitors MERCK & CO., INC. (US) 1993-04-13 US disclosed
US-5185251-A Treatment of HIV and AIDS MERCK & CO., INC. (US) 1993-02-09 US disclosed
EP-0481802-A1 Hydroxylated inhibitors of HIV reverse transcriptase MERCK & CO. INC. (US) 1992-04-22 EP disclosed
EP-0462800-A2 Inhibitors of HIV reverse transcriptase MERCK & CO. INC. (US) 1991-12-27 EP disclosed